miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway

Published:2015-03-12 Issue:5 Volume:55 Page:575-585
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Zhang Weiguang¹²,Shen Chen¹²,Li Chenguang¹²,Yang Guang¹²,Liu Huailei¹²,Chen Xin¹²,Zhu Dan³,Zou Huichao¹²,Zhen Yunbo¹²,Zhang Daming¹²,Zhao Shiguang¹²

Affiliation:

1. Department of Neurosurgery; The First Affiliated Hospital of Harbin Medical University; Harbin Heilongjiang Province China

2. Institute of Brain Science; Harbin Medical University; Harbin Heilongjiang Province China

3. Department of Neurology; The Second Affiliated Hospital of Harbin Medical University; Harbin Heilongjiang Province China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference41 articles.

1. Malignant gliomas in adults;Wen;N Engl J Med,2008

2. Molecularly targeted therapy for malignant glioma;Sathornsumetee;Cancer,2007

3. Status quo-Standard-of-care medical and radiation therapy for glioblastoma;Becker;Cancer J,2012

4. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

5. Low-grade gliomas in adults;Grier;Oncologist,2006

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting LRP6: A new strategy for cancer therapy;Pharmacological Research;2024-06

2. Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma;Journal of Orthopaedic Surgery and Research;2024-01-13

3. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities;Pathology - Research and Practice;2024-01

4. Hsa_circRNA_0084043 promoting tumorigenesis in glioma through miR-577 sponging;Heliyon;2023-09

5. LncRNA DSCAM-AS1: A Pivotal Therapeutic Target in Cancer;Mini-Reviews in Medicinal Chemistry;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3